These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18954532)
1. Recombinant interferon-alpha2b poly(lactic-co-glycolic acid) microspheres: pharmacokinetics-pharmacodynamics study in rhesus monkeys following intramuscular administration. Zhang YM; Yang F; Yang YQ; Song FL; Xu AL Acta Pharmacol Sin; 2008 Nov; 29(11):1370-5. PubMed ID: 18954532 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of recombinant human interferon-alpha-2b poly(lactic-co-glycolic acid) microspheres in rats. Yang F; Shu YJ; Yang YQ; Song FL; Pan YF; Long XY; Chen G; Zhang YM J Microencapsul; 2011; 28(6):483-9. PubMed ID: 21718088 [TBL] [Abstract][Full Text] [Related]
3. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres. Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486 [TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816 [TBL] [Abstract][Full Text] [Related]
6. Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial. De Leede LG; Humphries JE; Bechet AC; Van Hoogdalem EJ; Verrijk R; Spencer DG J Interferon Cytokine Res; 2008 Feb; 28(2):113-22. PubMed ID: 18279106 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of interferon-loaded magnetic biodegradable microspheres. Zhou S; Sun J; Sun L; Dai Y; Liu L; Li X; Wang J; Weng J; Jia W; Zhang Z J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):189-96. PubMed ID: 18437713 [TBL] [Abstract][Full Text] [Related]
8. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres. Liu B; Dong Q; Wang M; Shi L; Wu Y; Yu X; Shi Y; Shan Y; Jiang C; Zhang X; Gu T; Chen Y; Kong W Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1474-9. PubMed ID: 21048339 [TBL] [Abstract][Full Text] [Related]
10. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles. Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975 [TBL] [Abstract][Full Text] [Related]
11. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation. Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674 [TBL] [Abstract][Full Text] [Related]
12. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation. Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858 [TBL] [Abstract][Full Text] [Related]
13. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
14. Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System. Huang Z; Chen X; Fu H; Wen X; Ma C; Zhang J; Wu C; Huang Y; Pan X; Wu C J Pharm Sci; 2017 Nov; 106(11):3363-3371. PubMed ID: 28736289 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Chu DF; Fu XQ; Liu WH; Liu K; Li YX Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic profiles of recombinant human erythropoietin-loaded poly(lactic-co-glycolic acid) microspheres in rats. Zhou XL; He JT; Du HJ; Fan YY; Wang Y; Zhang HX; Jiang Y Acta Pharmacol Sin; 2012 Jan; 33(1):137-44. PubMed ID: 22139004 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice. Sato H; Wang YM; Adachi I; Horikoshi I Biol Pharm Bull; 1996 Dec; 19(12):1596-601. PubMed ID: 8996646 [TBL] [Abstract][Full Text] [Related]
18. Comparative Pharmacokinetics, Tissue Distribution, Excretion of Recombinant Liver-Targeting Interferon with IFN α2b Administered Intramuscular in Rats. Wang J; Lu X; Jin X; Zeng W; Zhu J Curr Pharm Biotechnol; 2015; 16(10):911-9. PubMed ID: 26278706 [TBL] [Abstract][Full Text] [Related]
19. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Sánchez A; Tobío M; González L; Fabra A; Alonso MJ Eur J Pharm Sci; 2003 Mar; 18(3-4):221-9. PubMed ID: 12659933 [TBL] [Abstract][Full Text] [Related]
20. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]